WeVote
Log In

Bill

Bill

A 5019

Requires pharmacy benefits manager compensation to be based on bona fide service fee.

2026-2027 Regular Session

The bill requires PBMs to be paid only via a bona fide, transparent service fee for defined services, restricting other opaque compensation like spread pricing.

Introduced, Referred to Assembly Financial Institutions and Insurance Committee
0
WeVote Research Nonpartisan
Bill Summary · A 5019

Summary of NJ Assembly Bill A-5019 (Session 222)

Title

Requires pharmacy benefits manager compensation to be based on bona fide service fee.

Purpose and intent

The bill establishes standards for how Pharmacy Benefits Managers (PBMs) compensate themselves for providing prescription drug coverage and related services. Its core aim is to ensure PBM compensation is derived from a bona fide service fee rather than potential exploitative practices, such as revenue tied to spread pricing or non-transparent ancillary charges. By tying compensation to verifiable services, the measure seeks to increase transparency, protect consumers and health plans, and reduce potential overcharging within PBM arrangements.

Key provisions and changes

  • Compensation basis: PBMs must base their compensation on a bona fide service fee. The bill likely defines what constitutes a bona fide service fee (e.g., a transparent, mutually agreed-upon fee for specific services such as claims processing, formulary management, network contracting, utilization review, and related administrative activities).
  • Restrictions on other compensation forms: The bill may restrict or prohibit other compensation mechanisms that can obscure true costs to payers and patients, such as markups, spread pricing, or rebates that are not disclosed as part of a service fee structure.
  • Transparency and disclosure: The legislation may require disclosures to the contracting entities (e.g., health plans, employers, or governments) about the basis of PBM compensation, including the components and amount of the bona fide service fee.
  • Contractual requirements: The bill could mandate model contract terms between PBMs and plan sponsors or pharmacy networks to standardize and enforce the bona fide service fee framework.
  • Compliance and enforcement: Provisions likely establish oversight mechanisms, potential penalties for non-compliance, and enforcement authority for relevant state departments or boards.
  • Effective date and phase-in: The bill would specify when the new compensation framework takes effect (e.g., upon enactment or a scheduled date) and whether there is a transitional period for PBMs to adjust existing contracts.

Who would be affected

  • Pharmacy Benefits Managers (PBMs): Primary actors responsible for adjusting compensation structures to align with bona fide service fees.
  • Health plans, employers, and state/federal government programs: Entities that contract with PBMs and pay for prescription drug benefits would be impacted by the new transparency and cost-structure requirements.
  • Pharmacies and drug manufacturers: Indirectly affected through contract negotiations, network participation, and potential changes in dispensing fees and rebates.
  • Consumers/ppatients: Potential indirect beneficiaries through improved price transparency, reduced overcharges, and more predictable out-of-pocket costs.

Procedural and timeline considerations

  • Legislative process: As an Assembly bill, it would need passage by the New Jersey General Assembly and a companion process in the Senate, followed by any necessary gubernatorial signature or veto.
  • Effective date: The act would specify when the new compensation rules become enforceable, with possible a phased implementation timeline to allow PBMs and plan sponsors to adjust.
  • Regulatory oversight: The bill may assign responsibility to a state department (e.g., Department of Banking and Insurance or Department of Health) for enforcement, rulemaking, and investigations of violations.

Notes

  • Specific definitions (e.g., what constitutes a bona fide service fee) and exact prohibited practices would be detailed in the bill text and any amendments.
  • The precise penalties, reporting requirements, and enforcement mechanisms would be outlined in the enacted statute or implementing regulations.

If you’d like, I can tailor this summary to include the exact statutory language once you provide the bill text or official fiscal notes, and I can add a section comparing it to current NJ PBM regulations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.